CNE000001840
CNE000001840
TIANJIN TIANYAO PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.908.035.192 | 3.215.285.233 | 9.6% |
| Cost of Revenue | 1.718.142.329 | 1.754.090.290 | 2.0% |
| Gross Profit | 1.189.892.863 | 1.461.194.943 | 18.6% |
| 888.115.445 | 1.146.121.680 | 22.5% | |
| Operating Income | 301.777.417 | 315.073.262 | 4.2% |
| Pretax Income | 122.109.770 | 226.513.091 | 46.1% |
| Net Income Common Stockholders | 70.564.419 | 133.450.643 | 47.1% |
| -- | -- | -- | |
| -- | -- | -- |